The Parkinson's disease VPS35 [D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human R Mir, F Tonelli, P Lis, T Macartney, NK Polinski, TN Martinez, MY Chou, ... Biochemical Journal 475 (11), 1861-1883, 2018 | 183 | 2018 |
Disturbed neurotransmitter homeostasis in ether lipid deficiency F Dorninger, T König, P Scholze, ML Berger, G Zeitler, C Wiesinger, ... Human Molecular Genetics 28 (12), 2046-2061, 2019 | 53 | 2019 |
Microtubules modulate F-actin dynamics during neuronal polarization B Zhao, DP Meka, R Scharrenberg, T König, B Schwanke, O Kobler, ... Scientific reports 7 (1), 9583, 2017 | 39 | 2017 |
Radial somatic F‐actin organization affects growth cone dynamics during early neuronal development DP Meka, R Scharrenberg, B Zhao, O Kobler, T König, I Schaefer, ... EMBO reports 20 (12), e47743, 2019 | 22 | 2019 |
Genetics of Alzheimer’s disease T König, E Stögmann Wiener Medizinische Wochenschrift 171 (11), 249-256, 2021 | 20 | 2021 |
Prescription patterns of antidementives in a high income country: A pharmacoepidemiologic study R Wurm, T Stamm, B Reichardt, F Schwarz, T Parvizi, S Silvaieh, T König, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 6 (1 …, 2020 | 10 | 2020 |
Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer’s disease T Parvizi, T König, R Wurm, S Silvaieh, P Altmann, S Klotz, PS Rommer, ... Frontiers in Aging Neuroscience 14, 887498, 2022 | 9 | 2022 |
User experience and acceptance of a device assisting persons with dementia in daily life: a multicenter field study T König, M Pigliautile, O Águila, J Arambarri, C Christophorou, ... Aging clinical and experimental research 34 (4), 869-879, 2022 | 7 | 2022 |
Reduction of physical activity during the COVID-19 pandemic is related to increased neuropsychiatric symptoms in memory clinic patients R Wurm, T Parvizi, S Silvaeih, E Berger–Sieczkowski, S Goeschl, T König, ... Clinical Medicine 22 (2), 177-180, 2022 | 6 | 2022 |
Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s disease S Gomes, A Garrido, F Tonelli, D Obiang, E Tolosa, MJ Martí, ... npj Parkinson's Disease 9 (1), 52, 2023 | 4 | 2023 |
C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients T König, R Wurm, T Parvizi, S Silvaieh, C Hotzy, H Cetin, S Klotz, E Gelpi, ... Neurobiology of Disease 175, 105927, 2022 | 4 | 2022 |
Multidimensional design research for dementia and its methodological opportunities for cross-disciplinary consortia K Dankl, E Stögmann, T König, S Moritsch, S Hanke The Design Journal 23 (4), 597-619, 2020 | 4 | 2020 |
Memento for living, working and caring: an ‘Archetypal Object’for being with dementia K Dankl, S Moritsch, F Pernkopf, E Stögmann, T König, S Hanke Dementia Lab 2019. Making Design Work: Engaging with Dementia in Context …, 2019 | 4 | 2019 |
Comprehensive genetic screening of early-onset dementia patients in an Austrian cohort-suggesting new disease-contributing genes S Silvaieh, T König, R Wurm, T Parvizi, E Berger-Sieczkowski, S Goeschl, ... Human genomics 17 (1), 55, 2023 | 3 | 2023 |
Co‐incidental C9orf72 expansion mutation‐related frontotemporal lobar degeneration pathology and sporadic Creutzfeldt−Jakob disease S Klotz, T König, M Erdler, A Ulram, A Nguyen, T Ströbel, A Zimprich, ... European Journal of Neurology 28 (3), 1009-1015, 2021 | 3 | 2021 |
Increased risk of death associated with the use of proton‐pump inhibitors in patients with dementia and controls–a pharmacoepidemiological claims data analysis H Cetin, R Wurm, B Reichardt, M Tomschik, S Silvaieh, T Parvizi, T König, ... European Journal of Neurology 27 (8), 1422-1428, 2020 | 3 | 2020 |
Usability testing of the first prototype of the Memento system: a technological device to promote an independent living in people with dementia M Pigliautile, T König, CC Mayer, M Colombo, AG Guazzarini, ... Disability and Rehabilitation: Assistive Technology 18 (8), 1411-1420, 2023 | 1 | 2023 |
Elevated urine BMPs-bis (Monoacylglycerol) Phosphates–in LRRK2 G2019S, R1441G/C and VPS35 D620N mutation carriers with and without Parkinson’s disease S Gomes, A Garrido, F Tonelli, D Obiang, E Tolosa, MJ Marti, ... medRxiv, 2022.08. 03.22278207, 2022 | 1 | 2022 |
Promising diagnostic accuracy of plasma Gfap and Nfl within the ad continuum T Parvizi, T Koenig, R Wurm, S Silvaieh, P Altmann, S Klotz, P Rommer, ... | 1 | 2021 |
Clinical heterogeneity within the ALS‐FTD spectrum in a family with a homozygous optineurin mutation T Parvizi, S Klotz, O Keritam, H Caliskan, S Imhof, T König, L Haider, ... Annals of Clinical and Translational Neurology, 2024 | | 2024 |